UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Burden of Clostridium difficile on the Healthcare System

Clinical infectious diseases, 2012-08, Vol.55 (suppl_2), p.S88-S92

2012

Volltextzugriff (PDF)

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Clinical infectious diseases, 2018-03, Vol.66 (7), p.e1-e48

2018

Volltextzugriff (PDF)

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Clinical infectious diseases, 2018-03, Vol.66 (7), p.987-994

2018

Volltextzugriff (PDF)

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

Clinical infectious diseases, 2018-09, Vol.67 (8), p.1198-1204

2018

Volltextzugriff (PDF)

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Clinical infectious diseases, 2018-08, Vol.67 (5), p.649-656

2018

Volltextzugriff (PDF)

The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection

Infectious disease clinics of North America, 2015-03, Vol.29 (1), p.123-134

2015

Volltextzugriff (PDF)

Clostridium difficile infection increases acute and chronic morbidity and mortality

Infection control and hospital epidemiology, 2019-01, Vol.40 (1), p.65-71

2019

Volltextzugriff (PDF)

Effectiveness of Screening Hospital Admissions to Detect Asymptomatic Carriers of Clostridium difficile: A Modeling Evaluation

Infection control and hospital epidemiology, 2014-08, Vol.35 (8), p.1043-1050

2014

Volltextzugriff (PDF)

Review of current literature on the economic burden of Clostridium difficile infection

Infection control and hospital epidemiology, 2009-01, Vol.30 (1), p.57-66

2009

Volltextzugriff (PDF)

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

BMC infectious diseases, 2022-03, Vol.22 (1), p.245-245, Article 245

2022

Volltextzugriff (PDF)

Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Therapeutic advances in gastroenterology, 2023-01, Vol.16, p.17562848231174277-17562848231174277

2023

Volltextzugriff (PDF)

Can prediction scores be used to identify patients at risk of Clostridioides difficile infection?

Current opinion in gastroenterology, 2022-01, Vol.38 (1), p.7-14

2022

Volltextzugriff (PDF)

Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice

Clinical transplantation, 2019-09, Vol.33 (9), p.e13564-n/a

2019

Volltextzugriff (PDF)

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

BMC infectious diseases, 2016-06, Vol.16 (1), p.303-303, Article 303

2016

Volltextzugriff (PDF)

Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient

Infectious disease clinics of North America, 2019-06, Vol.33 (2), p.485-500

2019

Volltextzugriff (PDF)

Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent Clostridioides difficile Infection

The New England journal of medicine, 2023-02, Vol.388 (7), p.654-656

2023

Volltextzugriff (PDF)

Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection

Infectious diseases and therapy, 2023-02, Vol.12 (2), p.703-709

2023

Volltextzugriff (PDF)

Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center

Anaerobe, 2014-02, Vol.25, p.5-10

2014

Volltextzugriff (PDF)

Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults

Cell reports (Cambridge), 2022-04, Vol.39 (2), p.110649-110649, Article 110649

2022

Volltextzugriff (PDF)

Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort

Clinical infectious diseases, 2021-01, Vol.72 (2), p.190-197

2021

Volltextzugriff (PDF)

Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset

Clinical infectious diseases, 2023-03, Vol.76 (5), p.809-815

2023

Volltextzugriff (PDF)

Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile Infections

Journal of Clinical Microbiology, 2011-08, Vol.49 (8), p.2887-2893

2011

Volltextzugriff (PDF)

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis

PloS one, 2016-02, Vol.11 (2), p.e0146822-e0146822

2016

Volltextzugriff (PDF)

Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections

mBio, 2019-08, Vol.10 (4)

2019

Volltextzugriff (PDF)

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

Genome medicine, 2021-02, Vol.13 (1), p.28-28, Article 28

2021

Volltextzugriff (PDF)

1 – 25 von 325

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(315)
Mit Volltextzugriff
(278)

Publikationsform

Artikel
(324)
Reviews
(1)

Sprache

Englisch
(325)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(188)
Life Sciences & Biomedicine
(187)
Humans
(147)
Infectious Diseases
(140)
Clostridium Difficile
(70)
Microbiology
(68)
Public, Environmental & Occupational Health
(59)
Female
(56)
Male
(56)
Infections
(53)
Immunology
(50)
Biological And Medical Sciences
(48)
Middle Aged
(48)
Medical Sciences
(47)
Aged
(46)
Adult
(45)
Hospitals
(43)
Risk Factors
(36)
Nursing
(35)
Antibiotics
(34)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Burden of Clostridium difficile on the Healthcare System

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)

Results From a Randomized, Placebo-Controlled Clinical Trial of a RBX2660-A Microbiota-Based Drug for the Prevention of Recurrent Clostridium difficile Infection

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

The Morbidity, Mortality, and Costs Associated with Clostridium difficile Infection

Clostridium difficile infection increases acute and chronic morbidity and mortality

Effectiveness of Screening Hospital Admissions to Detect Asymptomatic Carriers of Clostridium difficile: A Modeling Evaluation

Review of current literature on the economic burden of Clostridium difficile infection

Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial

Safety of fecal microbiota, live-jslm (REBYOTA™) in individuals with recurrent Clostridioides difficile infection: data from five prospective clinical trials

Can prediction scores be used to identify patients at risk of Clostridioides difficile infection?

Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice

Epidemiological and economic burden of Clostridium difficile in the United States: estimates from a modeling approach

Cytomegalovirus Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patient

Oral Vancomycin as Secondary Prophylaxis for Prevention of Recurrent Clostridioides difficile Infection

Final Results from a Phase 2b Randomized, Placebo-Controlled Clinical Trial of RBX2660: A Microbiota-Based Drug for the Prevention of Recurrent Clostridioides difficile Infection

Incidence and mortality associated with Clostridium difficile infection at a Japanese tertiary care center

Acute and persistent effects of commonly used antibiotics on the gut microbiome and resistome in healthy adults

Epidemiology of Left Ventricular Assist Device Infections: Findings From a Large Nonregistry Cohort

Costs Attributable to Clostridioides difficile Infection Based on the Setting of Onset

Impact of Clinical Symptoms on Interpretation of Diagnostic Assays for Clostridium difficile Infections

Identification of Medicare Recipients at Highest Risk for Clostridium difficile Infection in the US by Population Attributable Risk Analysis

Comparative Genomics of Antibiotic-Resistant Uropathogens Implicates Three Routes for Recurrence of Urinary Tract Infections

Microbiota restoration reduces antibiotic-resistant bacteria gut colonization in patients with recurrent Clostridioides difficile infection from the open-label PUNCH CD study

Suchergebnisse filtern